Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2
暂无分享,去创建一个
P. Mease | D. Baeten | J. Sieper | F. E. Van den Bosch | A. Pangan | I. Song | Yinglin Xia | Su Chen